Invicta Diagnostic Limited operates as a public limited company specializing in diagnostic services within the Mumbai Metropolitan Region (MMR) under the brand name 'PC Diagnostics.' Established initially as a Limited Liability Partnership in January 2021, the company transitioned to Private Limited status in December 2023 and later expanded to Public Limited status in July 2024. Invicta Diagnostic now focuses on radiology and pathology solutions, offering a comprehensive suite of imaging and clinical laboratory testing services through its network of eight diagnostic centers and a centralized laboratory in Maharashtra.
The business was founded by radiologists and first-generation entrepreneurs, Dr. Ketan Jayantilal Jain and Dr. Sanket Vinod Jain, with over 10 and 7 years of experience respectively in diagnostics. Together with Chief Financial Officer, Rohit Prakash Srivastava, the leadership team blends technical healthcare expertise with financial and operational management. From its inception, the company has expanded its service offerings, encompassing advanced imaging technologies like MRI, CT, and PET CT scans alongside basic echocardiograms, X-rays, and ultrasounds. Its pathology services span routine biochemical and clinical tests to niche offerings such as high-end molecular diagnostics and cytogenetics.
Through strategic acquisitions, Invicta Diagnostic has grown its footprint, acquiring majority stakes in diagnostic centers and facilities such as PCD Diagnostics, Primacare Healthcare LLP, and Pratham MRI and CT Scan Centre in 2023. In 2024, further acquisitions bolstered operations with facilities in Sewri, Parel, and Kalwa. The centralized laboratory in Parel enhances its efficiency and scalability in delivering diagnostics services across the MMR.
The company is on the cusp of growth, planning an Initial Public Offering (IPO) of 30,08,000 fresh equity shares to strengthen its operations and fund upcoming strategic initiatives. This move aims to capitalize on its established footprint and solidify its presence in one of India's key healthcare markets.
